• June 3-6, 2024
  • San Diego Convention Center, California

Start-Up Stadium

Start-Up Stadium at BIO 2024

Start-Up Stadium is designed to provide start-up companies with the opportunity to engage key members of the investment community, venture philanthropy groups, strategic partners, and non-dilutive capital at the world’s largest biotechnology partnering event.

During the 2024 BIO International Convention select finalists from around the world will share a quick pitch showcasing new technologies and therapeutic solutions to a panel of investor judges, followed by live feedback.  Finalists will be eligible for a highly discounted registration rate to attend the 2024 BIO International Convention.  

 

start up stadium
 

The deadline to apply has passed. 

New this year!

This year will also feature evaluation of the presentations from seed-stage company finalists (less than $1M raised) separate from emerging company finalists (more than $1M but less than $10M raised to date). with a winner identified for each category. Past prizes have included 'fast-track' admission review to incubator programs at the  Illumina Accelerator and  The Innovation Space, as well as complimentary, one-year memberships in the Biotechnology Innovation Organization with access to the cost-savings programs of  BIO Business Solutions.  

Application Deadline:  11:59 PM ET on February 15, 2024. 

Typical Requirements for Applicants: 

  • Raised less than $10 million since inception 

  • Fewer than 20 full-time employees 

  • Previous business pitch or competition experience 

  • Must not be a previous Start-Up Stadium winner

Need Advice on Your Pitch Deck?

Download our pitch presentation guide for additional insight and advice on building a stellar submission,

Download

Congratulations to our 2023 Seed-Stage and Emerging Winners

2023 SEED-STAGE START-UP WINNER

PriZm Therapeutics

Chandler, Arizona

Learn More

2023 EMERGING START-UP WIINNER

Paradox Immunotherapeutics

Learn more

2023 Seed-Stage Finalists

Company Website

48Hour Discovery
Azora Therapeutics
Clinials
Cyta Therapeutics
Delymer Therapeutics
Guardian Bio
ImunoTera
Mirscience Therapeutics
Moleculex co., ltd.
NCMN Bio
PriZm Therapeutics [Winner]
ReNewVax Ltd
RT MicroDx
Saros Therapeutics
StemSight
T-E Meds, Inc.
VaxSyna, Inc.

Main Therapeutic Focus

Platform for Therapeutics
Immunology
Tools/Drug Development Support Tech
Metabolic Diseases
Gene/Cell Therapy
Oncology
Immunology
Regenerative Medicine
Inflammation
Platform for Therapeutics
Orphan/Rare Diseases
Vaccines
Diagnostics
Oncology
Regenerative Medicine
Oncology
Vaccines

Company Location

Canada
United States (California)
Australia
United States (Massachusetts)
United States (Massachusetts)
United States (Massachusetts)
Brazil
Brazil
Taiwan
United States (Virginia)
United States (Arizona)
United Kingdom
United States (Massachusetts)
United States (Illinois)
Finland
Taiwan
United States (New Hampshire

2023 Emerging Start-Up Finalists

AnHorn Medicines Co., Ltd.
Anticipate Bioscience
ARCE Therapeutics
Ardan Pharma
ARIZ Precision Medicine
Asgard Therapeutics
AyuVis Research, Inc.
CorriXR Therapeutics
ElectraTect, Inc.
Enquyst Technologies Inc
FAKnostics,LLC
FELIQS Corporation
Genius Holdings Co., Ltd
Gilboa Therapeutics
Grannus Therapeutics, Inc.
Immuto Scientific
LASE Innovation
Limax Biosciences, Inc.
March Biosciences
MC Sciences
MelliCell, Inc
Neuroene Therapeutics
OmniCyte
pacDNA Therapeutics
Paradox Immunotherapeutics  [Winner]
Promakhos Therapeutics
Reference Medicine
Reglagene
Swaza
Zehna Therapeutics Inc

Platform for Therapeutics
Oncology
Oncology
Oncology
Oncology
Oncology
Immunology
Oncology
Diagnostics
Tools/Drug Development Support Tech
Oncology
Ophthalmology
Respiratory
Oncology
Oncology
Platform for Therapeutics
Tools/Drug Development Support Tech
Inflammation
Oncology
Platform for Therapeutics
Metabolic Diseases
CNS/Neurological
Oncology
Platform for Therapeutics
Immunology
Inflammation
Diagnostics
CNS/Neurological
Respiratory
Metabolic Diseases

Taiwan
United States (Arizona)
Taiwan
Argentina
United States (California)
Sweden
United States (Texas)
United States (Delaware)
United States (Arizona)
United States (Massachusetts)
United States (Arizona)
Japan
Taiwan
Israel
United States (Indiana)
United States (Wisconsin)
United States (Massachusetts)
United States (Massachusetts)
United States (Texas)
Germany
United States (Massachusetts)
United States (District Of Columbia)
United States (Connecticut)
United States (Massachusetts)
Canada
United States (Massachusetts)
United States (Arizona)
United States (Arizona)
United States (California)
United States (Ohio)

BIO Thanks the 2023 Participating BIO Start-Up Stadium Judges:

  • Christopher Aleong, Chief Business Officer, Lumosa Therapeutics; Managing Director, BioEngine Capital
  • Gad Berdugo, Managing Partner, Explorium Capital LLC
  • David H. Crean, PhD, Managing General Partner, Cardiff Advisory LLC
  • Kevin Emesiani, PharmD, Senior Associate, Medical Excellence Capital, LLC
  • Bettina Ernst, Director, BERNINA BioInvest
  • Gail Christine Gannon, CEO of Ensanté & Director, Neurotech Collider Lab, UC Berkeley
  • Lu Han, PhD, Partner, Lumira Ventures
  • Mike Huckman, Global Practice Leader, Executive Communications, Real Chemistry
  • Scott M. Kahn, PhD, Founder, Alykomed Global Solutions LLC
  • George MacDougall, Director, Investor Relations & Corporate Communications, Gritstone bio, Inc.
  • Stephanie Marrus, Managing Director of Entrepreneurship, Innovation Ventures, UCSF
  • Anton Neschadim, PhD, Senior Advisor, GreenSky Capital
  • Vinit Nijhawan, Managing Director, MassVentures
  • Younes Ouahid, PhD, Partner, Facultas Partners
  • William D. Provine, PhD, President & CEO, Innovation Space
  • Ryan Roller, Managing Director, Life Science & Healthcare, HSBC
  • Lesley Stolz, PhD, VP, Early Innovation Partnering, Johnson & Johnson Innovation
  • Kitty Wu, PhD, VP, Head of Business Development and Strategy, Fosun Pharma USA
  • Samuel Wu, MD, PhD, Venture Partner, 7G BioVentures
  • John Zhu, PhD, Founder and President, Mayewell Capital

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSOR